CC
REGN icon

Centiva Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Centiva Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254K Sell
408
-14,202
-97% -$9.67M ﹤0.01% 1261
2026
Q1 		$11.3M Buy
+14,610
New +$11.2M 0.08% 164
2025
Q3 		– Sell
-431
Closed -$244K – 1721
2025
Q2 		$226K Buy
+431
New +$241K ﹤0.01% 1289
2025
Q1 		– Sell
-604
Closed -$430K – 2035
2024
Q4 		$430K Buy
+604
New +$507K 0.01% 913
2024
Q3 		– Sell
-66
Closed -$73.4K – 2522
2024
Q2 		$69.4K Sell
66
-421
-86% -$408K ﹤0.01% 1900
2024
Q1 		$469K Buy
487
+460
+1,704% +$437K 0.01% 1024
2023
Q4 		$23.7K Sell
27
-1,380
-98% -$1.14M ﹤0.01% 1668
2023
Q3 		$1.16M Buy
+1,407
New +$1.11M 0.03% 565
2023
Q1 		– Sell
-1,016
Closed -$766K – 1780
2022
Q4 		$733K Buy
1,016
+716
+239% +$528K 0.02% 660
2022
Q3 		$207K Sell
300
-3,271
-92% -$2.06M ﹤0.01% 1168
2022
Q2 		$2.11M Buy
3,571
+1,141
+47% +$742K 0.05% 339
2022
Q1 		$1.7M Buy
+2,430
New +$1.54M 0.03% 496
2021
Q4 		– Sell
-749
Closed -$461K – 1488
2021
Q3 		$454K Sell
749
-2,135
-74% -$1.33M 0.03% 653
2021
Q2 		$1.61M Buy
2,884
+452
+19% +$229K 0.04% 399
2021
Q1 		$1.15M Buy
+2,432
New +$1.18M 0.04% 305
2020
Q1 		– Sell
-1,466
Closed -$550K – 869
2019
Q4 		$550K Buy
+1,466
New +$493K 0.03% 407
2019
Q3 		– Sell
-558
Closed -$175K – 704
2019
Q2 		$175K Sell
558
-5,775
-91% -$1.92M 0.01% 349
2019
Q1 		$2.6M Buy
6,333
+3,671
+138% +$1.51M 0.17% 94
2018
Q4 		$994K Buy
+2,662
New +$974K 0.08% 141

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Centiva Capital's REGN Position: Q2 2026 in Review

Centiva Capital reduced its Regeneron Pharmaceuticals (REGN) stake by 97% in Q2 2026, selling an estimated $9.67M and leaving 408 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #1261.

Centiva Capital first reported a position in REGN in Q4 2018 and has held it in 19 quarters since. The position peaked at $11.3M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Centiva Capital held 408 shares of Regeneron Pharmaceuticals worth $254K as of Q2 2026.
  • Centiva Capital sold 14,202 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $9.67M.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1261 holding.
  • Centiva Capital first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 19 quarters since.
  • Centiva Capital's Regeneron Pharmaceuticals position peaked at $11.3M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.